Latest News

Key research into the treatment of osteoarthritis is set to be strengthened with the Kolling’s Professor David Hunter receiving a large NHMRC investigator grant. The highly competitive grant was awarded to the Florance and Cope Chair of Rheumatology for a five-year project to transform treatment options and delivery of care for osteoarthritis. Professor Hunter welcomed the grant, saying ..... Read more

At a time when the world is looking to medical research for answers, the Kolling Institute is directing its resources and expertise to broaden our understanding of the COVID-19 virus and improve treatments. Executive Director Professor Carolyn Sue discusses the valuable research efforts across the Kolling to support the community through this pandemic. Read more

For many people with COVID-19, the first sign they had the virus was a loss in their sense of smell. Now a team from the Kolling Institute and Royal North Shore Hospital will investigate the correlation between the virus and early symptoms. Study lead Associate Professor Rory Clifton-Bligh said a loss of smell has emerged as a common symptom of COVID-19 infection, but the current data is..... Read more

Kolling Institute researchers are a key part of a new Northern Sydney Local Health District COVID-19 Clinical Research Group. All major specialist disciplines are represented in the group, taking advantage of the breadth of knowledge across the health campus. Kolling researcher Associate Professor Clifton-Bligh said we formed the group because we saw a clear need to co-ordinate our clin..... Read more

For many people with heart disease there’s an increased level of anxiety around the implications of COVID-19, but it’s hoped a new study led by Royal North Shore Hospital will guide future treatment and improve health outcomes. Head of cardiology Professor Ravinay Bhindi has launched the AUS-COVID study, which will involve more than 800 patients in over 20 hospitals across Australia. Th..... Read more

A world-first study by a team from the Kolling Institute may inform the future use of multiple medications by older people, minimising adverse impacts including frailty. The longitudinal research is the first preclinical study to demonstrate that multiple medications can impair function in old age, and that stopping some can reduce harm. Research lead, Professor Sarah Hilmer said until ..... Read more

2020 is an important year for the Kolling Institute as it marks the 100 year anniversary of the research organisation. As the longest-running medical research institute in New South Wales, the Kolling has a very rich history. Originally named the Institute of Pathological Research of NSW, the organisation was established in a cottage within the grounds of Royal North Shore Hospital in 1..... Read more

For nearly three decades, the Kolling Institute Tumour Bank has been quietly and consistently building a large state resource. It was established in 1992 with a small number of endocrine tumours. Today, it also has breast, colorectal and gynaecological tumour collections, as well as neurological and gastrointestinal samples. The significance of the resource has been recognised in recent..... Read more

Professor Mark Molloy’s ground-breaking bowel cancer research has received a boost, with the Cancer Council NSW awarding the Kolling Institute researcher a three-year $450,000 grant. Professor Molloy has welcomed the funding, saying bowel cancer claims more lives each year than breast, prostate or skin cancer. “It is now Australia’s second biggest cancer killer, with more than 300 Austra..... Read more

Read more